Charles Debattista
Professor of Psychiatry and Behavioral Sciences at Stanford University
Key Impact
He is a Stanford psychiatrist and depression researcher who appears on multiple ketamine and psilocybin clinical studies, making him a notable academic contributor to psychedelic psychiatry and rapid-acting antidepressant research.
Background & Research
Charles DeBattista is a Stanford psychiatrist specializing in treatment-resistant depression, clinical psychopharmacology, and neuromodulation. He directs the Depression Research Clinic at Stanford and has published extensively on biological and pharmacologic treatments for mood disorders. His recent collaborative work includes studies of ketamine and psilocybin in depression and suicidal ideation.
Collaboration Network
33 collaborators· click a node to visit their profile
Full network →